Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad176 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Cong Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide 500…. Hauptthemen laut MEDLINE: Incretins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Context
Premenopausal women are at a lower risk of type 2 diabetes (T2D) compared to men, but the underlying mechanism(s) remain elusive. The secretion of the incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), from the small intestine is a major determinant of glucose homeostasis and may be influenced by sex.
Objectives
This study compared blood glucose and plasma insulin and incretin responses to intraduodenal glucose infusions in healthy young males and females.
Design
In Study 1, 9 women and 20 men received an intraduodenal glucose infusion at 2 kcal/min for 60 minutes. In Study 2, 10 women and 26 men received an intraduodenal glucose at 3 kcal/min for 60 minutes. Venous blood was sampled every 15 minutes for measurements of blood glucose and plasma insulin, GLP-1 and GIP.
Results
In response to intraduodenal glucose at 2 kcal/min, the incremental area under the curve between t = 0-60 minutes (iAUC0-60min) for blood glucose and plasma GIP did not differ between the 2 groups. However, iAUC0-60min for plasma GLP-1 (P = 0.016) and insulin (P = 0.011) were ∼2-fold higher in women than men. In response to intraduodenal glucose at 3 kcal/min, iAUC0-60min for blood glucose, plasma GIP, and insulin did not differ between women and men, but GLP-1 iAUC0-60min was 2.5-fold higher in women (P = 0.012).
Conclusion
Healthy young women exhibit comparable GIP but a markedly greater GLP-1 response to intraduodenal glucose than men. This disparity warrants further investigations to delineate the underlying mechanisms and may be of relevance to the reduced risk of diabetes in premenopausal women when compared to men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide 5000, Australia.
- Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide 5000, Australia.
- School of Medicine, Southeast University, Nanjing 210009, China.
- Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide 5000, Australia.
ORCID-Profile: Karen L Jones, Michael Horowitz, Tongzhi Wu
Zitieren
APA
Xie, C., Huang, W., Sun, Y., Xiang, C., Trahair, L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2023). Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad176
Vancouver
Xie C, Huang W, Sun Y, Xiang C, Trahair L, Jones KL, et al. Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad176
BibTeX
@article{Xie2023,
author = {Xie, Cong and Huang, Weikun and Sun, Yixuan and Xiang, Chunjie and Trahair, Laurence and Jones, Karen L and Horowitz, Michael and Rayner, Christopher K and Wu, Tongzhi},
title = {Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad176}
}
EUVIMED